Website & contact details
- Website
Magnitude Biosciences Limited
- Incorporated
- 20 September 2018 (8 years)
- Industry
- Research and experimental development on biotechnology (72110)
- Owned by
- The Noth East (Erdf) Innovation Fund Limited Partnership
- Accounts type
- Total exemption full
- Region
- North East
- Address
- Netpark PlexusThomas Wright WaySedgefieldTS21 3FD
Filing status
- Accounts due
- 30 November 2027
- Last accounts
- 28 February 2026
- Conf. stmt due
- 10 September 2027
- Last conf. stmt
- 27 August 2026
Officers
This list may be incomplete. See all officers on Companies House
Officer details are public data from the Companies House register.
Director · Appointed 1 July 2025
British
Born May 1975 (51)
British
Born December 1981 (44)
Director · Appointed 14 February 2022
British
Born June 1958 (68)
Saunter, Christopher David, Dr
Director · Appointed 20 September 2018
British
Born May 1979 (47)
Officer history (1 former)
1 July 2025
3 October 2022
14 June 2022
Resigned O'Brien, John as Director
14 February 2022
20 September 2018
Appointed Saunter, Christopher David, Dr as Director
20 September 2018
Appointed O'Brien, John as Director
Ownership 1 active
People and entities with significant control, from the Companies House PSC register
The Noth East (Erdf) Innovation Fund Limited Partnership
Corporate entity · Notified 19 September 2019
Owns 25–50% of shares
Holds 25–50% of voting rights
Right to appoint and remove directors
Limited Partnership
Former controllers (2)
31 March 2025
Ceased Treerunner Holdings Limited — Owns 25–50% of shares
30 November 2018
Ceased David Weinkove — Owns 25–50% of shares
Financials
Balance sheet as at 28 February 2026 · total exemption full accounts
- Net Assets
- £117,232
- Cash
- £139,978
- Debt Ratio
- 67%
- Current Ratio
- 1.3x
Trend
Net Assets
Balance sheet detail
| 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
| Fixed Assets | £46,248 | £44,710 | £44,218 | £49,331 | £51,374 | £55,384 |
| Current Assets | £311,416 | £336,781 | £341,662 | £255,415 | £151,087 | £206,231 |
| Debtors | £171,438 | £177,585 | £126,119 | £161,677 | ||
| Cash | £139,978 | £159,196 | £215,543 | £93,738 | ||
| Creditors (< 1 year) | £240,432 | £339,056 | £82,973 | £55,867 | £14,639 | £5,379 |
| Creditors (> 1 year) | £0 | £1,264 | £2,350 | £4,162 | ||
| Net Current Assets | £70,984 | (£2,275) | £258,689 | £199,548 | £143,744 | £203,701 |
| Net Assets | £117,232 | £42,185 | £301,643 | £246,529 | £184,305 | |
| Shareholder Funds | £117,232 | £42,185 | £301,643 | £246,529 | £184,305 | £259,085 |
What Magnitude Biosciences say about themselves
“Contract C. elegans services for your research area · Ageing · Neurodegeneration · Muscle Health · Gut Health · Disease Modelling · Metabolic Health.”
Filings
Recent filings only. See the full history on Companies House
| Date | Description | Made Up To | Pages | |
|---|---|---|---|---|
| 27 August 2026 | Confirmation statement with updates | 27 August 2026 | ||
| 19 August 2026 | Other filing | |||
| 14 August 2026 | Memorandum and Articles of Association | |||
| 14 August 2026 | Particulars of variation of rights attached to shares | |||
| 14 August 2026 | Resolutions |
Some other companies at this address
Other companies in this industry
Newcastle Upon Tyne
Edinburgh
Edinburgh
Need accounts figures, ownership or websites for thousands of companies? Bulk data & API →